Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis

The aim of this study was to systematically review and meta-analyze published data on the diagnostic performance of combined 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in the detection of primary tumors in patients with cancer of unknown primary (CUP). A systematic search for relevant studies was performed of the PubMed/MEDLINE and Embase databases. Methodological quality of the included studies was assessed. Reported detection rates, sensitivities and specificities were meta-analyzed. Subgroup analyses were performed if results of individual studies were heterogeneous. The 11 included studies, comprising a total sample size of 433 patients with CUP, had moderate methodological quality. Overall primary tumor detection rate, pooled sensitivity and specificity of FDG-PET/CT were 37%, 84% (95% CI 78–88%) and 84% (95% CI 78–89%), respectively. Sensitivity was heterogeneous across studies (P = 0.0001), whereas specificity was homogeneous across studies (P = 0.2114). Completeness of diagnostic workup before FDG-PET/CT, location of metastases of unknown primary, administration of CT contrast agents, type of FDG-PET/CT images evaluated and way of FDG-PET/CT review did not significantly influence diagnostic performance. In conclusion, FDG-PET/CT can be a useful method for unknown primary tumor detection. Future studies are required to prove the assumed advantage of FDG-PET/CT over FDG-PET alone and to further explore causes of heterogeneity.

[1]  J. Hainsworth,et al.  Neoplasms of Unknown Primary Site , 2002 .

[2]  O. Mundler,et al.  [Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor]. , 2006, Annales d'Oto-Laryngologie et de Chirurgie Cervico-Faciale.

[3]  Tinsu Pan,et al.  PET/CT imaging techniques, considerations, and artifacts. , 2006, Journal of thoracic imaging.

[4]  D. Visvikis,et al.  Impact of combined 18F-FDG PET/CT in head and neck tumours , 2005, British Journal of Cancer.

[5]  R. Engers,et al.  Diagnostic strategies in cervical carcinoma of an unknown primary (CUP) , 2002, European Archives of Oto-Rhino-Laryngology.

[6]  I. Haas,et al.  Comments on the publication: Haas I. et al. (2001) The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 258: 177-183 , 2002, European Archives of Oto-Rhino-Laryngology.

[7]  Johannes B Reitsma,et al.  Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies , 2006, BMC medical research methodology.

[8]  Kyle E. Rusthoven,et al.  The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor , 2004, Cancer.

[9]  C. Claussen,et al.  [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging]. , 2008, Der Radiologe.

[10]  D V Schapira,et al.  The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. , 1995, Archives of internal medicine.

[11]  P. Bossuyt,et al.  BMC Medical Research Methodology , 2002 .

[12]  J. Mackey,et al.  The role of 2‐deoxy‐2‐[F‐18]fluoro‐D‐glucose positron emission tomography in disseminated carcinoma of unknown primary site , 2007, Cancer.

[13]  N. Pavlidis.  Forty years experience of treating cancer of unknown primary , 2007, Acta oncologica.

[14]  C. Nanni,et al.  Role of 18F-FDG PET–CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  T. Turkington,et al.  Clinical applications of PET in oncology. , 2004, Radiology.

[16]  J. Debatin,et al.  Unknown primary tumors: detection with dual-modality PET/CT--initial experience. , 2005, Radiology.

[17]  Peter R. Luijten,et al.  Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology , 2008, European Radiology.

[18]  T. Chevalier,et al.  Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. , 1988, Archives of internal medicine.

[19]  M. Ladd,et al.  Feasibility of whole-body MR with T2- and T1-weighted real-time steady-state free precession sequences during continuous table movement to depict metastases. , 2008, Radiology.

[20]  Heoung Keun Kang,et al.  FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[21]  S. Stoeckli,et al.  FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary , 2007, European Archives of Oto-Rhino-Laryngology.

[22]  W. Shockley,et al.  Use, Accuracy, and Implications for Patient Management of [18F]‐2‐Fluorodeoxyglucose‐Positron Emission/Computerized Tomography for Head and Neck Tumors , 2005, The Laryngoscope.

[23]  R. Delgado-Bolton,et al.  Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  J. Pimiento,et al.  Cancer of unknown primary origin: a decade of experience in a community-based hospital. , 2007, American journal of surgery.

[25]  G. Antoch,et al.  Dual Modality of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Patients with Cervical Carcinoma of Unknown Primary , 2005, Medical Principles and Practice.

[26]  O. Mundler,et al.  Apport du TEP scanner au [18F]-FDG dans les adénopathies cervicales primitives , 2006 .

[27]  G. Karcher,et al.  Impact de la tomographie par émission de positons au 18fluorodésoxyglucose dans la prise en charge des cancers de primitif inconnu , 2007 .

[28]  T. Pan,et al.  Pitfalls in Integrated CT-PET of the Thorax: Implications in Oncologic Imaging , 2006, Journal of thoracic imaging.

[29]  R. Rödel,et al.  PET-CT-Bildgebung bei Kopf-Hals-Tumoren , 2004, Der Radiologe.

[30]  E. Gontier,et al.  In search of an unknown primary tumour presenting with cervical metastases: Performance of hybrid FDG-PET–CT , 2007, Nuclear medicine communications.

[31]  F. Fischbach,et al.  Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness , 2003, European Radiology.

[32]  N. Hall,et al.  Impact of [18F]‐2‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography on Previously Untreated Head and Neck Cancer Patients , 2007, The Laryngoscope.

[33]  O. Belohlávek,et al.  Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  V. Ambrosini,et al.  18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin , 2006, La radiologia medica.

[35]  R. Semelka,et al.  Emerging techniques: Whole‐body screening and staging with MRI , 2006, Journal of magnetic resonance imaging : JMRI.

[36]  K. Chorneyko,et al.  The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center. , 2005, Annals of diagnostic pathology.

[37]  J. Abbruzzese,et al.  Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  M. Mancini,et al.  Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[39]  Barton F Branstetter,et al.  Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[40]  Javier Zamora,et al.  Meta-DiSc : a software for meta-analysis of test accuracy data , 2015 .

[41]  Gerald Antoch,et al.  Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  J. Chydenius.  Strahlenschaden des Darmes und der Harn-Blase bei der Radiumbehandlung des Carcinoma Colli Uteri , 1942 .

[43]  R. Rödel.  PET/CT imaging in head and neck tumors. , 2008, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[44]  C. Claussen,et al.  Kostenüberlegungen zur Ganzkörper-MRT und PET-CT im Rahmen des onkologischen Stagings , 2008, Der Radiologe.

[45]  Habib Zaidi,et al.  Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[46]  P. Aschoff,et al.  [The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?]. , 2006, Laryngo- rhino- otologie.

[47]  Thomas F Hany,et al.  Integrated PET/CT: current applications and future directions. , 2006, Radiology.

[48]  J. Barkhausen,et al.  Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography , 2007, Acta radiologica.

[49]  Jeffrey N. Myers,et al.  Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma , 2003, Head & neck.

[50]  J. Mayordomo,et al.  Neoplasms of Unknown Primary Site: A Clinicopathological Study of Autopsied Patients , 1993, Tumori.

[51]  E. Melhem,et al.  Whole body turbo STIR MRI in unknown primary tumor detection , 1998, Journal of magnetic resonance imaging : JMRI.

[52]  J. Hainsworth,et al.  Diagnostic and therapeutic management of cancer of an unknown primary. , 2003, European journal of cancer.

[53]  O. Yalcin,et al.  Isolated Bone Metastasis in Testicular Germ Cell Tumors: A Case Report and Review of the Literature , 2006, Oncology Research and Treatment.

[54]  V. Runge,et al.  Safety of magnetic resonance contrast media. , 2001, Topics in magnetic resonance imaging : TMRI.

[55]  C. Meltzer,et al.  PET/CT: form and function. , 2007, Radiology.

[56]  R. Hagen,et al.  Das integrierte PET/CT: Technischer Fortschritt in der Diagnostik von Kopf-Hals-Karzinom-Rezidiven und CUP? , 2005 .